Literature DB >> 24929283

Revision total hip arthroplasty with a modular cementless femoral stem.

Christoper E Pelt1, Wes Madsen1, Jill A Erickson1, Jeremy M Gililland1, Mike B Anderson1, Christopher L Peters1.   

Abstract

We retrospectively reviewed 123 patients who underwent cementless THA with modular femoral stem designs for revision THA or conversion of failed ORIF and found 75 patients available for analysis. The Harris Hip Score (HHS) improved from 52 ± 14 to 86 ± 11 (P < 0.001). The femoral stem was re-revised in eight patients (11%). The mean time to re-revision was 1.1years (0.13-2.54). Reasons for re-revision included infection (n = 5, 7%), aseptic loosening (n = 2, 3%) and significant pain (n = 1, 1%). There were no failures of the modular junctions. PC stems had an increased rate of intraoperative fractures (PC 28% vs. STS 9%, P = 0.04). Modular cementless femoral stems provide acceptable mid-term results in revision THA.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cementless femoral stem; modular femoral stem; revision total hip arthroplasty; taper junction; total hip arthroplasty

Mesh:

Year:  2014        PMID: 24929283     DOI: 10.1016/j.arth.2014.04.042

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  3 in total

Review 1.  A systematic review of the causes of failure of Revision Total Hip Arthroplasty.

Authors:  Connor Kenney; Steven Dick; Justin Lea; Jiayong Liu; Nabil A Ebraheim
Journal:  J Orthop       Date:  2019-05-02

2.  Early outcomes after revision total hip arthroplasty with a modern modular femoral revision stem in 65 consecutive cases.

Authors:  Christopher E Pelt; Marissa L Stagg; Christin Van Dine; Mike B Anderson; Christopher L Peters; Jeremy M Gililland
Journal:  Arthroplast Today       Date:  2018-11-17

3.  Comparison of modular and nonmodular tapered fluted titanium stems in femoral revision hip arthroplasty: a minimum 6-year follow-up study.

Authors:  Shuo Feng; Yu Zhang; Yu-Hang Bao; Zhi Yang; Guo-Chun Zha; Xiang-Yang Chen
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.